T. Rowe Price Associates’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $234K | Sell |
|
|||||
|
2021
Q4 | $231K | Buy |
|
|||||
|
2021
Q3 | $98K | Sell |
|
|||||
|
2021
Q2 | $22M | Buy |
|
|||||
|
2021
Q1 | $24.5M | Sell |
|
|||||
|
2020
Q4 | $22.8M | Sell |
|
|||||
|
2020
Q3 | $30.1M | Sell |
|
|||||
|
2020
Q2 | $24M | Sell |
|
|||||
|
2020
Q1 | $20.5M | Buy |
|
|||||
|
2019
Q4 | $46.6M | Buy |
|
|||||
|
2019
Q3 | $55.6M | Sell |
|
|||||
|
2019
Q2 | $57.1M | Sell |
|
|||||
|
2019
Q1 | $107M | Buy |
|
|||||
|
2018
Q4 | $82M | Sell |
|
|||||
|
2018
Q3 | $166M | Buy |
|
|||||
|
2018
Q2 | $146M | Buy |
|
|||||
|
2018
Q1 | $82.8M | Sell |
|
|||||
|
2017
Q4 | $105M | Buy |
|
|||||
|
2017
Q3 | $82.7M | Sell |
|
|||||
|
2017
Q2 | $106M | Sell |
|
|||||
|
2017
Q1 | $184M | Buy |
|
|||||
|
2016
Q4 | $137M | Buy |
|
|||||
|
2016
Q3 | $160M | Buy |
|
|||||
|
2016
Q2 | $184M | Buy |
|
|||||
|
2016
Q1 | $134M | Buy |
|
|||||
|
2015
Q4 | $108M | Buy |
|
|||||
|
2015
Q3 | $43.6M | Buy |
|
|||||
|
2015
Q2 | $36M | Buy |
|
|||||
|
2015
Q1 | $23.6M | Buy |
|